Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Wang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Discovery Medicine|August 14, 2010
Acute stroke managementJames J Wang
Discovery Medicine|August 14, 2010
Industry Analysis: Erbitux and targeted therapies for cancerBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry Trends: Gene discovery by deCODE GeneticsBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry News: Avastin approved for metastatic colorectal cancerBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry Analysis: Tarceva extends cancer patients survival in a phase III studyBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry Trends: Antegren -- Novel drug for autoimmune diseasesBenjamin Yang, James J Wang
The Journal of Emergency Medicine|October 12, 2014
Impact of an emergency medicine decision support and risk education system on computed tomography and magnetic resonance imaging useTony J Carnevale, Di Meng, James J Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2010
Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) miceXinli Zhang, Kang Ting, Catherine M Bessette, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2015
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitorsEric Therrien, Guillaume Larouche, Natalie Nguyen, et al.
Molecular Cancer Therapeutics|April 17, 2008
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivoMarielle Fournel, Claire Bonfils, Yu Hou, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Discovery Medicine|August 14, 2010
Acute stroke managementJames J Wang
Discovery Medicine|August 14, 2010
Industry Analysis: Erbitux and targeted therapies for cancerBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry Trends: Gene discovery by deCODE GeneticsBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry News: Avastin approved for metastatic colorectal cancerBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry Analysis: Tarceva extends cancer patients survival in a phase III studyBenjamin Yang, James J Wang
Discovery Medicine|August 14, 2010
Industry Trends: Antegren -- Novel drug for autoimmune diseasesBenjamin Yang, James J Wang
The Journal of Emergency Medicine|October 12, 2014
Impact of an emergency medicine decision support and risk education system on computed tomography and magnetic resonance imaging useTony J Carnevale, Di Meng, James J Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2010
Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) miceXinli Zhang, Kang Ting, Catherine M Bessette, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2015
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitorsEric Therrien, Guillaume Larouche, Natalie Nguyen, et al.
Molecular Cancer Therapeutics|April 17, 2008
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivoMarielle Fournel, Claire Bonfils, Yu Hou, et al.
Pageof 1